Beilin Le
Director/Board Member at Mirxes Holding Co., Ltd.
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Zou Ruiyang | M | 38 |
Mirxes Holding Co., Ltd.
 Mirxes Holding Co., Ltd. Financial ConglomeratesFinance Mirxes Holding Co., Ltd. operates as an investment holding company. It is engaged in developing and commercializing blood-based miRNA test kit products for the early detection of cancer and other diseases. The firm’s business segments include Infectious Diseases and Early Detection and Precision Multi-Omics. The Infectious Diseases segment engages in development, manufacture, supply of diagnostic kits and provision of infectious disease clinical testing. The Early Detection and Precision Multi-Omics involves in Development, manufacture, supply of diagnostic & life sciences products, and provision of research profiling, clinical testing and clinical services. The company was founded by Too Heng Phon, Zhou Lihan and Zou Ruiyang in 2014 and is headquartered in Singapore.
National University of Singapore
| 13 years |
| Zhou Lihan | M | 40 |
Mirxes Holding Co., Ltd.
Mirxes Holding Co., Ltd. Financial ConglomeratesFinance Mirxes Holding Co., Ltd. operates as an investment holding company. It is engaged in developing and commercializing blood-based miRNA test kit products for the early detection of cancer and other diseases. The firm’s business segments include Infectious Diseases and Early Detection and Precision Multi-Omics. The Infectious Diseases segment engages in development, manufacture, supply of diagnostic kits and provision of infectious disease clinical testing. The Early Detection and Precision Multi-Omics involves in Development, manufacture, supply of diagnostic & life sciences products, and provision of research profiling, clinical testing and clinical services. The company was founded by Too Heng Phon, Zhou Lihan and Zou Ruiyang in 2014 and is headquartered in Singapore. | 10 years |
| Lo Ling Ma | F | 39 |
Mirxes Holding Co., Ltd.
Mirxes Holding Co., Ltd. Financial ConglomeratesFinance Mirxes Holding Co., Ltd. operates as an investment holding company. It is engaged in developing and commercializing blood-based miRNA test kit products for the early detection of cancer and other diseases. The firm’s business segments include Infectious Diseases and Early Detection and Precision Multi-Omics. The Infectious Diseases segment engages in development, manufacture, supply of diagnostic kits and provision of infectious disease clinical testing. The Early Detection and Precision Multi-Omics involves in Development, manufacture, supply of diagnostic & life sciences products, and provision of research profiling, clinical testing and clinical services. The company was founded by Too Heng Phon, Zhou Lihan and Zou Ruiyang in 2014 and is headquartered in Singapore. | - |
| Lee Meng Lim | M | 68 |
Mirxes Holding Co., Ltd.
Mirxes Holding Co., Ltd. Financial ConglomeratesFinance Mirxes Holding Co., Ltd. operates as an investment holding company. It is engaged in developing and commercializing blood-based miRNA test kit products for the early detection of cancer and other diseases. The firm’s business segments include Infectious Diseases and Early Detection and Precision Multi-Omics. The Infectious Diseases segment engages in development, manufacture, supply of diagnostic kits and provision of infectious disease clinical testing. The Early Detection and Precision Multi-Omics involves in Development, manufacture, supply of diagnostic & life sciences products, and provision of research profiling, clinical testing and clinical services. The company was founded by Too Heng Phon, Zhou Lihan and Zou Ruiyang in 2014 and is headquartered in Singapore. | 3 years |
| Tai San Noah Lim | M | 49 |
Mirxes Holding Co., Ltd.
Mirxes Holding Co., Ltd. Financial ConglomeratesFinance Mirxes Holding Co., Ltd. operates as an investment holding company. It is engaged in developing and commercializing blood-based miRNA test kit products for the early detection of cancer and other diseases. The firm’s business segments include Infectious Diseases and Early Detection and Precision Multi-Omics. The Infectious Diseases segment engages in development, manufacture, supply of diagnostic kits and provision of infectious disease clinical testing. The Early Detection and Precision Multi-Omics involves in Development, manufacture, supply of diagnostic & life sciences products, and provision of research profiling, clinical testing and clinical services. The company was founded by Too Heng Phon, Zhou Lihan and Zou Ruiyang in 2014 and is headquartered in Singapore. | 3 years |
| Hou Chiat Ho | M | 48 |
Mirxes Holding Co., Ltd.
Mirxes Holding Co., Ltd. Financial ConglomeratesFinance Mirxes Holding Co., Ltd. operates as an investment holding company. It is engaged in developing and commercializing blood-based miRNA test kit products for the early detection of cancer and other diseases. The firm’s business segments include Infectious Diseases and Early Detection and Precision Multi-Omics. The Infectious Diseases segment engages in development, manufacture, supply of diagnostic kits and provision of infectious disease clinical testing. The Early Detection and Precision Multi-Omics involves in Development, manufacture, supply of diagnostic & life sciences products, and provision of research profiling, clinical testing and clinical services. The company was founded by Too Heng Phon, Zhou Lihan and Zou Ruiyang in 2014 and is headquartered in Singapore. | 6 years |
| Too Heng-Phon | M | 65 |
Mirxes Holding Co., Ltd.
Mirxes Holding Co., Ltd. Financial ConglomeratesFinance Mirxes Holding Co., Ltd. operates as an investment holding company. It is engaged in developing and commercializing blood-based miRNA test kit products for the early detection of cancer and other diseases. The firm’s business segments include Infectious Diseases and Early Detection and Precision Multi-Omics. The Infectious Diseases segment engages in development, manufacture, supply of diagnostic kits and provision of infectious disease clinical testing. The Early Detection and Precision Multi-Omics involves in Development, manufacture, supply of diagnostic & life sciences products, and provision of research profiling, clinical testing and clinical services. The company was founded by Too Heng Phon, Zhou Lihan and Zou Ruiyang in 2014 and is headquartered in Singapore. | 10 years |
| Ming Hsieh | M | 68 |
Fudan University
| 13 years |
| Da Liu | M | 53 |
Mirxes Holding Co., Ltd.
Mirxes Holding Co., Ltd. Financial ConglomeratesFinance Mirxes Holding Co., Ltd. operates as an investment holding company. It is engaged in developing and commercializing blood-based miRNA test kit products for the early detection of cancer and other diseases. The firm’s business segments include Infectious Diseases and Early Detection and Precision Multi-Omics. The Infectious Diseases segment engages in development, manufacture, supply of diagnostic kits and provision of infectious disease clinical testing. The Early Detection and Precision Multi-Omics involves in Development, manufacture, supply of diagnostic & life sciences products, and provision of research profiling, clinical testing and clinical services. The company was founded by Too Heng Phon, Zhou Lihan and Zou Ruiyang in 2014 and is headquartered in Singapore. | 3 years |
| Li Xin Yan | M | 60 |
Fudan University
| 16 years |
| Yuet Chew Siow | F | 57 |
Mirxes Holding Co., Ltd.
Mirxes Holding Co., Ltd. Financial ConglomeratesFinance Mirxes Holding Co., Ltd. operates as an investment holding company. It is engaged in developing and commercializing blood-based miRNA test kit products for the early detection of cancer and other diseases. The firm’s business segments include Infectious Diseases and Early Detection and Precision Multi-Omics. The Infectious Diseases segment engages in development, manufacture, supply of diagnostic kits and provision of infectious disease clinical testing. The Early Detection and Precision Multi-Omics involves in Development, manufacture, supply of diagnostic & life sciences products, and provision of research profiling, clinical testing and clinical services. The company was founded by Too Heng Phon, Zhou Lihan and Zou Ruiyang in 2014 and is headquartered in Singapore. | 1 years |
| Zhao Chen | M | 51 |
Fudan University
| 17 years |
| Hong Gao Hu | M | 70 |
Fudan University
| 17 years |
| Jiong Yu | F | 67 |
Fudan University
| 17 years |
| Kotaro Tamura | M | 60 |
National University of Singapore
| 10 years |
| Hong Qi Yuan | M | 54 |
Fudan University
| 15 years |
| Gui Xiang Ma | M | 59 |
Fudan University
| 15 years |
| Beng Lor Choo | M | 52 |
Mirxes Holding Co., Ltd.
Mirxes Holding Co., Ltd. Financial ConglomeratesFinance Mirxes Holding Co., Ltd. operates as an investment holding company. It is engaged in developing and commercializing blood-based miRNA test kit products for the early detection of cancer and other diseases. The firm’s business segments include Infectious Diseases and Early Detection and Precision Multi-Omics. The Infectious Diseases segment engages in development, manufacture, supply of diagnostic kits and provision of infectious disease clinical testing. The Early Detection and Precision Multi-Omics involves in Development, manufacture, supply of diagnostic & life sciences products, and provision of research profiling, clinical testing and clinical services. The company was founded by Too Heng Phon, Zhou Lihan and Zou Ruiyang in 2014 and is headquartered in Singapore. | 4 years |
| Hon Chew Chan | M | 58 |
National University of Singapore
| 9 years |
| Yuen Khong Siow | M | 69 |
National University of Singapore
| 9 years |
| Hui Ming Zhang | M | 68 |
Fudan University
| 14 years |
| Wei Zhi Owyong | F | - |
Mirxes Holding Co., Ltd.
Mirxes Holding Co., Ltd. Financial ConglomeratesFinance Mirxes Holding Co., Ltd. operates as an investment holding company. It is engaged in developing and commercializing blood-based miRNA test kit products for the early detection of cancer and other diseases. The firm’s business segments include Infectious Diseases and Early Detection and Precision Multi-Omics. The Infectious Diseases segment engages in development, manufacture, supply of diagnostic kits and provision of infectious disease clinical testing. The Early Detection and Precision Multi-Omics involves in Development, manufacture, supply of diagnostic & life sciences products, and provision of research profiling, clinical testing and clinical services. The company was founded by Too Heng Phon, Zhou Lihan and Zou Ruiyang in 2014 and is headquartered in Singapore. | 3 years |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Chong Huat Tan | M | 61 |
National University of Singapore
| 6 years |
| Ya Chao Zhao | F | 41 |
Fudan University
| 7 years |
| Da Chuan Sha | M | 38 |
Fudan University
| 5 years |
| Rui Jin Xiao | M | - |
Fudan University
| 6 years |
| Xiao Yi Ma | M | 50 |
Fudan University
| 2 years |
| Xing Hai Wang | M | 43 |
Fudan University
| 4 years |
| Yun Gao | F | 35 |
Fudan University
| 4 years |
| Tan Wei Hao | M | - |
National University of Singapore
| 4 years |
| Xian Feng Cao | M | 49 |
Fudan University
| 4 years |
| Si Yu Shen | M | 42 |
Fudan University
| 3 years |
| Zhi Hua Zhang | M | 43 |
Fudan University
| 1 years |
| Yi Lun Liu | M | 38 |
Fudan University
| 4 years |
| Bernice Z.M. Chay | F | - |
National University of Singapore
| 4 years |
| Weihua Tang | M | 55 |
Fudan University
| 2 years |
| Xinshu Dong | M | - |
National University of Singapore
| 5 years |
| Xinxin Liu | F | 46 |
Fudan University
| 2 years |
| Yi Bing Wu | M | 42 |
Fudan University
| 3 years |
| Na Zhang | M | 43 |
Fudan University
| 3 years |
| Tong Xu | M | - |
Fudan University
| 4 years |
| Weiye Sun | M | 32 |
Fudan University
| 4 years |
| Xing Qianqian | F | - |
National University of Singapore
| 4 years |
| Wen Yi Shen | M | 36 |
Fudan University
| 4 years |
| Yi Qun Xu | F | 41 |
Fudan University
| 4 years |
| Chenguang Ma | F | 46 |
Fudan University
| 2 years |
| Ming Xu | M | 41 |
Fudan University
| 1 years |
| Lei Yao | M | 35 |
National University of Singapore
| 4 years |
| Yu Qing Huang | M | 34 |
Fudan University
| 4 years |
| Wee Kiat Tan | M | 36 |
National University of Singapore
| 3 years |
| Ying Xu | F | 47 |
Fudan University
| 2 years |
| Brandon Tee | M | - |
National University of Singapore
| 5 years |
| Claire Yuen | F | - |
National University of Singapore
| 4 years |
| Xiao Yuan Feng | M | 67 |
Fudan University
| 4 years |
| Xing Huang | M | 50 |
Fudan University
| 2 years |
| Ze kai Chen | M | 60 |
National University of Singapore
| 2 years |
| Guanghua Li | M | 49 |
Fudan University
| 2 years |
| Kevin Koh | M | - |
National University of Singapore
| 4 years |
| Hui Yang | F | 41 |
Fudan University
| 3 years |
| Bei Li Wang | F | 38 |
Fudan University
| 4 years |
| Jacob Zhou | M | - |
Fudan University
| 4 years |
| Rong Cheng Cai | M | - |
Fudan University
| 4 years |
| Ying Cai | F | 44 |
Fudan University
| 1 years |
| Chuan Xin Zhao | M | 59 |
Fudan University
| 1 years |
| Jian Tao Xiong | M | 56 |
Fudan University
| 4 years |
| Yun Fan Zhang | M | 45 |
National University of Singapore
| 2 years |
| Chi Fei Zhang | M | - |
Fudan University
| 4 years |
| Ping Hu Gui | M | 65 |
Fudan University
| 2 years |
| Zheng Kui Wu | M | 50 |
Fudan University
| 1 years |
| Ji Chen | M | 49 |
Fudan University
| 3 years |
| Xiao Feng Zhang | M | 47 |
Fudan University
| 1 years |
| Fei Chen | M | 44 |
Fudan University
| 3 years |
| Jian Qiu Zhou | F | 55 |
Fudan University
| 2 years |
| Hock Huat Yeo | M | 60 |
National University of Singapore
| 2 years |
| Da Huang | M | 41 |
Fudan University
| 1 years |
| Jessica Koh | F | - |
National University of Singapore
| 5 years |
| Sijie Pu | M | 48 |
Fudan University
| 2 years |
| Shu Min Zhu | M | 64 |
Fudan University
| 2 years |
| Mars Cao | M | - |
Fudan University
| 3 years |
| He Tong Lou | M | 62 |
Fudan University
| 3 years |
| Sai Ye Gu | F | 51 |
Fudan University
| 2 years |
| Erica Zhang | F | - |
Fudan University
| 4 years |
| Min Zhu | F | 56 |
National University of Singapore
| 2 years |
| Xian Ya Lin | M | 48 |
Fudan University
| 2 years |
| Zhi Jiong Zhang | M | 44 |
Fudan University
| 2 years |
| Regina Ho | F | - |
National University of Singapore
| 4 years |
| Yong Tian Chew | M | 77 |
National University of Singapore
| 34 years |
| Yong Mei Zhang | F | 44 |
Fudan University
| 2 years |
| Nicola Honorati | M | - |
Fudan University
| 1 years |
| Daryl Chew | M | - |
National University of Singapore
| 3 years |
| Shou Dong Wang | M | 46 |
Fudan University
| 2 years |
| Zi Sheng Xie | M | 58 |
Fudan University
| 2 years |
| Lemon Zhang | F | - |
National University of Singapore
| 4 years |
| Xiao Xin Li | M | 45 |
Fudan University
| 3 years |
| Jian Rong Luo | M | 61 |
Fudan University
| 2 years |
| Jie Luo | M | - |
Fudan University
| 1 years |
| Wei Ping Wang | M | 73 |
Fudan University
| 6 years |
| Andrés López Bech | M | - |
National University of Singapore
| - |
| Zhihui Wang | F | - |
Fudan University
| 5 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| China | 65 | 65.66% |
| Singapore | 34 | 34.34% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Beilin Le
- Personal Network
